Dysregulation of miRNAs is associated with depression [43, 53], hence miRNAs may be useful therapeutic targets and are indeed targets of effective antidepressants; the SSRI, fluoxetine decreases levels of miR-16 (regulates BDNF) in mouse hippocampus [54]. Here, BDNF is linked to depressive symptom measurement.